Skip to content

A prospective exploratory study on the usefulness of Asialoglycoprotein Receptor Imaging in patients with Acute liver damage early in onset in Osaka City University (ARIA-OCU)

A prospective exploratory study on the usefulness of Asialoglycoprotein Receptor Imaging in patients with Acute liver damage early in onset in Osaka City University (ARIA-OCU) - Asialoglycoprotein Receptor Imaging in patients with Acute liver damage in Osaka City University (ARIA-OCU)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033058
Enrollment
15
Registered
2018-06-25
Start date
2018-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute liver damage

Interventions

We perform asialoglycoprotein receptor imaging in patients with acute liver damage within 3 weeks and 1 to 2 months after the onset of acute liver damage. The dose of Tc-99m-GSA used for each asialogl

Sponsors

Osaka City University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Over 20 years old. 2. Asialoglycoprotein receptor imaging can be performed within 3 weeks from the onset of acute liver damage. The definition of acute liver damage is "patients showing alanine transferase values of 100 IU/L or more or total bilirubin values of 3.0 mg/dL or more due to acute liver damage, where the liver function prior to the current onset of liver damage is estimated to have been normal based on laboratory tests and imaging tests.

Exclusion criteria

Exclusion criteria: 1. Severe psychiatric disorder or psychiatric symptom is merged. (provided, however, judged by the attending physician.) 2. Asialoglycoprotein receptor imaging can not be performed due to poor general condition. 3. Long-term resting supine position is difficult due to back pain. 4. Pregnant or lactating woman. 5. In a case that the researchers judge it is difficult to carry out the study.

Design outcomes

Primary

MeasureTime frame
Percentage of patients in whom chief physician judge 2nd asialoglycoprotein receptor imaging to be meaningful.

Secondary

MeasureTime frame
1. Comparison of treatment policies before and after asialoglycoprotein receptor imaging, and a rate of treatment policy change. 2. Percentage of patients falling into acute liver failure. 3. Correlation between the duration until falling into acute liver failure and quantitative value of asialoglycoprotein receptor imaging and its rate of change. 4. Correlation between the duration of liver damage status and quantitative value of asialoglycoprotein receptor imaging and its rate of change. 5. Percentage of patients who develop hepatic coma above II degree. 6. Correlation between the duration until developing hepatic coma above II degree and quantitative value of asialoglycoprotein receptor imaging and its rate of change. 7. Percentage of patients who died from acute liver failure. 8. Correlation between the duration until death due to acute liver failure and quantitative value of asialoglycoprotein receptor imaging and its rate of change.

Countries

Japan

Contacts

Public ContactKohei Kotani

Osaka City University Graduate School of Medicine Hepatology

kouhei-k@med.osaka-cu.ac.jp06-6645-3905

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026